Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries

Tools

Ostuzzi, Giovanni and Gastaldon, Chiara and Petrini, Carlo and Godman, Brian and Barbui, Corrado (2020) Poor implementation of the EU clinical trial regulation is a major threat for pragmatic trials in European countries. Epidemiology and Psychiatric Sciences, 29 (6). e126. ISSN 2045-7960 (https://doi.org/10.1017/S2045796020000396)

[thumbnail of Ostuzzi-etal-EPS-2020-Poor-implementation-of-the-eu-clinical-trial-regulation]
Preview
 Text. Filename: Ostuzzi_etal_EPS_2020_Poor_implementation_of_the_eu_clinical_trial_regulation.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo
Download (155kB)| Preview

Abstract

The principle of pragmatism in clinical trials has been broadly recognised as a way to close the gap between research and practice. In this contribution, we argue that the conduct of pragmatic clinical trials in Europe may be hampered by poor implementation of current European Union's Clinical Trial Regulation No. 536/2014.

CORE (COnnecting REpositories)